Compounds > miglustat
Page last updated: 2024-08-23

miglustat and glucosamine

miglustat has been researched along with glucosamine in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's7 (53.85)18.2507
2000's2 (15.38)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA1
Jacob, GS; Karlsson, GB; Platt, FM1
Balwierz, PS; Gad, SC; Guzzie, PJ; Oshiro, Y; Rohrbacher, E; Soelter, SG1
Bowlin, TL; Kang, MS; Liu, PS; Sunkara, PS; Taylor, DL; Tyms, AS1
Dedera, D; Ratner, L; vander Heyden, N2
Fujimoto, K; Kornfeld, R1
Jacob, GS; Jones, IM1
Eto, Y1
Etou, Y1

Reviews

3 review(s) available for miglustat and glucosamine

ArticleYear
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
    Journal of medicinal chemistry, 2013, Apr-11, Volume: 56, Issue:7

    Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship

2013
[Is it possible to treat the brain? Recent advances in inherited neurodegenerative disorders].
    No to hattatsu = Brain and development, 2007, Volume: 39, Issue:2

    Topics: 1-Deoxynojirimycin; Bone Marrow Transplantation; Cell- and Tissue-Based Therapy; Enzyme Inhibitors; Enzyme Therapy; Genetic Therapy; Glucosamine; Heredodegenerative Disorders, Nervous System; Humans; Stem Cell Transplantation

2007
[Recent therapeutics for Fabry disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Apr-10, Volume: 98, Issue:4

    Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Cell- and Tissue-Based Therapy; Fabry Disease; Genetic Therapy; Glucosamine; Humans; Isoenzymes; Mass Screening; Trihexosylceramides

2009

Other Studies

10 other study(ies) available for miglustat and glucosamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycin.
    European journal of biochemistry, 1992, Aug-15, Volume: 208, Issue:1

    Topics: 1-Deoxynojirimycin; Antiviral Agents; Cell Line; Cell Membrane; Glucosamine; Glycoside Hydrolases; HIV; Humans; Kinetics; Receptors, Transferrin; Transferrin

1992
Genetic toxicology studies of an anti-AIDS drug.
    Toxicology letters, 1992, Volume: 60, Issue:3

    Topics: 1-Deoxynojirimycin; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Bone Marrow; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Female; Glucosamine; Hypoxanthine Phosphoribosyltransferase; Male; Mice; Mice, Inbred Strains; Micronucleus Tests; Salmonella

1992
6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
    AIDS (London, England), 1991, Volume: 5, Issue:6

    Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Cell Line; Cell Line, Transformed; Dose-Response Relationship, Drug; Gene Products, env; Glucosamine; Glycoside Hydrolase Inhibitors; HIV Envelope Protein gp120; HIV Envelope Protein gp160; HIV-1; Humans; Indolizines; Mice; Moloney murine leukemia virus; Protein Precursors; Viral Plaque Assay; Zalcitabine

1991
Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity.
    Virology, 1991, Volume: 181, Issue:1

    Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Glucosamine; Glycoside Hydrolase Inhibitors; HIV; Humans; Kinetics; Models, Biological; Oligosaccharides; Recombination, Genetic; RNA-Directed DNA Polymerase; Simian Immunodeficiency Virus; Vaccinia virus; Viral Envelope Proteins; Viral Plaque Assay; Virus Replication

1991
alpha-Glucosidase II-deficient cells use endo alpha-mannosidase as a bypass route for N-linked oligosaccharide processing.
    The Journal of biological chemistry, 1991, Feb-25, Volume: 266, Issue:6

    Topics: 1-Deoxynojirimycin; alpha-Glucosidases; alpha-Mannosidase; Animals; Chromatography, Affinity; Chromatography, Paper; Glucosamine; Glycoside Hydrolase Inhibitors; Kinetics; Lymphoma; Mannosidases; Mice; Mutation; Oligosaccharides; Tumor Cells, Cultured

1991
Anti-HIV drug mechanism.
    Nature, 1991, Jul-18, Volume: 352, Issue:6332

    Topics: 1-Deoxynojirimycin; Antiviral Agents; Glucosamine; HIV; HIV Envelope Protein gp120; Protein Conformation

1991
Attenuation of HIV-1 infectivity by an inhibitor of oligosaccharide processing.
    AIDS research and human retroviruses, 1990, Volume: 6, Issue:6

    Topics: 1-Deoxynojirimycin; Amino Sugars; Antiviral Agents; Glucosamine; Glucosidases; HIV-1; Humans; Oligosaccharides; Virulence

1990
Several new AIDS drugs being tested.
    Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:6

    Topics: 1-Deoxynojirimycin; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; CD4 Antigens; Drug Therapy, Combination; Glucosamine; Humans; Interferon Type I; Sarcoma, Kaposi; Zalcitabine; Zidovudine

1989
Experimental treatments for HIV-infected patients.
    American family physician, 1989, Volume: 39, Issue:6

    Topics: 1-Deoxynojirimycin; Antiviral Agents; Glucosamine; HIV Envelope Protein gp160; HIV Seropositivity; Humans; Immunotherapy; Recombinant Proteins; Retroviridae Proteins; Vaccines, Synthetic; Viral Envelope Proteins; Viral Vaccines

1989